WaveEdge Capital LLC, an independent healthcare and life sciences investment bank, served as exclusive sell-side M&A advisor to Sequoia Health, a California multi-specialty independent physician association, in connection with its sale to Tri-Valley Medical Group.
LOS ANGELES, March 7, 2024 /PRNewswire-PRWeb/ -- WaveEdge Capital LLC ("WaveEdge"), an independent healthcare and life sciences investment bank, served as exclusive sell-side M&A advisor to Sequoia Health ("Sequoia"), a California multi-specialty independent physician association, in connection with its sale to Tri-Valley Medical Group ("Tri-Valley"). "We are pleased to have worked with these stellar teams to complete a transaction with such potential for future growth and expanded services for patients", said John Selig, Managing Partner, WaveEdge.
Sequoia, one of the largest IPAs in central California, has more than 1300 of the leading primary care and specialty physician networks, including 45 FQHC clinics in the Greater Central Valley owned by Sequoia's minority partner, Golden Valley Health Centers. Sequoia serves over 145,000 lives in Merced, San Joaquin, and Stanislaus counties. Physicians offer a wide range of healthcare services, including pediatrics, adult primary care, urgent care centers and specialist care.
Tri-Valley, a portfolio company of Webster Equity Partners, is a highly innovative physician platform that provides primary care and population health management services to Senior and Commercial members in Southern California. The company has a 20+ year history and demonstrated success in risk-based contracts with leading health plans and IPA partners. The company's high-touch care model provides a comprehensive suite of clinical services to patients and is integrated across outpatient clinics, skilled nursing facilities, and hospital settings. The clinical model has been highly successful in delivering significant cost savings to payors and the healthcare system driven by active care coordination for members, specialty care utilization management, and reduction in hospital admissions/re-admission and inpatient bed days, while achieving consistently high-quality measures and improved clinical outcomes.
About WaveEdge Capital:
WaveEdge is an independent investment bank providing experienced M&A advisory services to lower middle market companies across the healthcare and life sciences space. Areas of specialization include single- and multi-specialty physician practices; outsourced provider services; outsourced pharmaceutical services; digital health; and behavioral health. WaveEdge's deal team was led by John Selig, Rose Maljanian and Jeff Karan.
For more information, visit www.waveedgecap.com.
Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client's experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the mergers & acquisitions industry and the strength of the healthcare sector of the U.S. economy, and the ability to attract and retain qualified employees.
Media Contact
John Selig, WaveEdge Capital LLC, 1 415.577.7783, [email protected], https://www.waveedgecap.com
SOURCE WaveEdge Capital LLC
Share this article